Cladribine tablets were tested against placebo in randomized controlled trials (RCTs). In this study, the effectiveness of cladribine vs other approved drugs in patients with relapsing-remitting MS (RRMS) was compared by matching RCT to observational data.
Cladribine vs other drugs in MS: Merging randomized trial with real-life data
Signori, Alessio;Laroni, Alice;Sormani, Maria Pia
2020-01-01
Abstract
Cladribine tablets were tested against placebo in randomized controlled trials (RCTs). In this study, the effectiveness of cladribine vs other approved drugs in patients with relapsing-remitting MS (RRMS) was compared by matching RCT to observational data.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
10.1212@NXI.0000000000000878.pdf
accesso aperto
Descrizione: articolo su rivista
Tipologia:
Documento in versione editoriale
Dimensione
546.57 kB
Formato
Adobe PDF
|
546.57 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
